The Scientific Programme is summarised below. Invited
Plenary and Keynote Lectures will be presented by distinguished
international scientists. There will be Symposia, Mini-Symposia, Workshops
(featuring invited lectures plus additional oral
communications selected from those submitted) and 12 Poster Sessions. Three special
Round-Table Discussions will be held, including one on:
"Generic Drugs and Intellectual Property Rights in the Global
Pharmaceutical Market."
Late-breaking Abstracts
Subject to the availability of space, Abstracts on late-breaking
research work will be rapidly
considered for poster presentation. Although Late-breaking Abstracts
will not be published in the Abstract Book, a copy of these abstracts will be distributed to participants. Please contact the EUFEPS '98 Organizing
Secretariat for further details.
Abstract Book
Accepted Abstracts received by the deadline will be published in
a supplement of the European Journal of Pharmaceutical Sciences
(Elsevier Science), with an official ISSN abstracted by all the major
abstracting agencies. This is the Official Journal of the European
Federation for Pharmaceutical Sciences. All participants will receive
the Abstract Book with the Final Programme at the Congress itself.
New EUFEPS Awards
Details of the new EUFEPS Young Investigator Awards presented in
Milan for outstanding research achievements in Poster Presentation
can be found below.
The Segre Award in Pharmacokinetics/Pharmacodynamics will
be presented for the first time at EUFEPS '98 in Milan. Further
details can be found in the General
Information section.
Synopsis of Scientific Programme
Morning, Friday,
September 11th.
|
Plenary
Lecture 1
|
Receptors As Drug
Targets
|
Plenary
Lecture 2
|
Challenges For Drug
Delivery
|
Poster Sessions
|
1, 2, 3, 4, 5
|
| |
Afternoon, Friday,
September 11th.
|
Round
Table
|
Generic Drugs And
Intellectual Property Rights In The Global Pharmaceutical Market
|
Mini-Symposium 1
|
New Trends In Alzheimer's
Disease
|
Workshop
1
|
Drug Delivery
|
Workshop
2
|
New Targets in Drug
Discovery
|
| |
Morning, Saturday,
September 12th.
|
Workshop
3
|
Drug Targeting (Organ Selectivity - Cell Targeting - Cell
Signalling)
|
Mini-Symposium 2
|
New Perspectives in
Analytical Chemistry
|
Symposium
|
Drugs and Cancer:
Experimental and Clinical Pharmacology of Tumours and
Apoptosis
|
Symposium
|
The 5th Framework
Programme:
Perspectives and Impact on European Research
|
Symposium
|
New Trends in
Bioavailability - Bioequivalence Studies
|
Poster Sessions
|
6, 7
|
| |
Afternoon, Saturday,
September 12th.
|
Workshop
4
|
Drug Metabolism And
Pharmacokinetics
|
Workshop
5
|
Chemical Development and
Drug Characterization
|
Mini-Symposium 3
|
Routes for Site-Specific
Delivery
|
Mini-Symposium 4
|
Biotechnology Drugs and the
Therapeutic Revolution
|
| |
Morning, Sunday,
September 13th.
|
Mini-Symposium 5
|
New Processes in Drug
Discovery
|
Workshop
7
|
Drug Delivery
|
Workshop
9
|
Challenges and Perspectives
in Natural Products
|
Round
Table
|
The Impact of Megamergers on
Drug Research and Development
|
Plenary
Lecture 3
|
Recombinant DNA Technology
And Vaccine Development
|
Poster Sessions
|
8, 9, 10, 11, 12
|
| |
Afternoon, Sunday,
September 13th.
|
Round
Table
|
Natural Food Modified by
Biotechnology:
Nutritional and Pharmaceutical Issues
|
Workshop
8
|
Cell Lines and Tissue
Culture in Drug Discovery and Development
|
Workshop
6
|
Pharmaceutical
Technology:
Material Science
|
9.30-12.00 FRIDAY, September 11
|
9.30 - 9.50
|
OPENING
REMARKS
|
|
|
9.50 - 10.00
|
AWARD IN HONOR OF PROF.
SEGRE
|
PLENARY LECTURE
1
10.00 - 10.45
|
Shankley N.P., Black J.W.
(London, UK)
RECEPTORS AS DRUG TARGETS
|
10.45 - 11.15
|
Break
|
|
|
PLENARY LECTURE
2
11.15 - 12.00
|
Breimer D.D. (Leiden, The Netherlands)
CHALLENGES FOR DRUG DELIVERY
|
12.00
|
End of the Session
|
|
|
|
|
Display 08.30 - 18.30 Discussion 13.00 - 14.30
|
Poster Session 1 - Drug Discovery: New Processes
Poster Session 2 - Drug Discovery: New Targets
Poster Session 3 - Drug Development: Chemical Synthesis
Poster Session 4 - Drug Development: Analytical Characterization
Poster Session 5 - Issues in Clinical Pharmacy
|
|
|
14.30-18.00 FRIDAY,
September 11
|
ROUND TABLE
GENERIC DRUGS AND
INTELLECTUAL PROPERTY
RIGHTS IN THE GLOBAL PHARMACEUTICAL MARKET
14.30 - 14.45
|
De Jong H.J. (Courbevoie, France)
INDUSTRIAL PERSPECTIVES
|
14.45 - 15.00
|
Bass R. (London, UK)
EMEA PERSPECTIVES
|
15.00 - 15.15
|
Bianchetti G. (Milan, Italy)
INTELLECTUAL PROPERTY ISSUES RELEVANT FOR GENERIC AND "BULK"
MANUFACTURERS
|
15.15 - 15.30
|
Fleischer N. (Washington, USA)
FDA PERSPECTIVES
|
15.30 - 16.30
|
General Discussion
|
16.30 - 17.00
|
Break
|
|
|
17.00 - 18.00
|
BRACCO PRIZE
|
|
|
18.00
|
End of the Session
|
14.30-16.30 FRIDAY,
September 11
|
MINI-SYMPOSIUM
1
NEW TRENDS IN
ALZHEIMER'S DISEASE
14.30 - 15.00
|
Hendriks L. (Antwerpen, Belgium)
ALZHEIMER'S DISEASE: FROM GENETICS TO PATHOPHYSIOLOGY
|
15.00 - 15.30
|
Govoni S. (Pavia, Italy)
BIOCHEMICAL MARKERS OF ALZHEIMER'S DISEASE
|
15.30 - 16.00
|
Bellosta S. (Milan, Italy)
USE OF TRANSGENIC MODELS IN THE EVALUATION OF NOVEL
THERAPEUTIC FOR ALZHEIMER'S DISEASE
|
16.00 - 16.30
|
Bauer J. (Freiburg, Germany)
ANTI-INFLAMMATORY SUBSTANCES AS A NEW THERAPEUTIC OPTION IN
ALZHEIMER'S DISEASE
|
16.30
|
End of the Session
|
14.30-18.00 FRIDAY,
September 11
|
WORKSHOP 1
DRUG DELIVERY
(Part I)
14.30 - 15.00
|
Colombo P. (Parma, Italy)
SWELLABLE MATRICES FOR ORAL CONTROLLED RELEASE: AN UPDATE ON
DELIVERY MECHANISM
|
15.00 - 15.15
|
Alhaique F. (Rome, Italy)
TWO POLYSACCHARIDES FOR CONTROLLED DRUG DELIVERY:
SCLEROGLUCAN AND GELLAN
|
15.15 - 15.30
|
Rowley G. (Sunderland, UK)
RELEASE MECHANISMS FOR DRUG/POLYMER FORMULATIONS IN HARD
GELATIN CAPSULES
|
15.30 - 15.45
|
Cortesi R. (Ferrara, Italy)
LIPOSOMES, MICELLES AND MICROEMULSIONS AS NEW DELIVERY
SYSTEMS FOR CAMPTOTHECIN
|
15.45 - 16.00
|
Adekova V. (London, UK)
COMPARATIVE RELEASE KINETICS OF SOME CO-POLYMERIC
NANOPARTICLES FOR DRUG DELIVERY
|
16.00 - 16.15
|
Sendil D. (Ankara, Turkey)
TETRACYCLINE RELEASE FROM BIODEGRADABLE POLYESTERS FOR
TREATMENT OF PERIODONTAL DISEASES
|
16.15 - 16.45
|
Break
|
WORKSHOP 1
DRUG DELIVERY
(Part
II)
16.45 - 17.00
|
Arunothayanun P. (London, UK)
APPROACHES TO A BIOMIMETIC DELIVERY DEVICE: RELEASE OF
SINGLE NIOSOMES FROM CAPILLARIES
|
17.00 - 17.15
|
Müller R.H. (Berlin, Germany)
NANOSUSPENSIONS OF POORLY SOLUBLE CYTOTOXICS: DESIGN OF A
LAB SCALE PRODUCTION UNIT
|
17.15 - 17.30
|
Walters P.A. (Sunderland, UK)
MOISTURE UPTAKE OF VEHICLES FOR LIQUID-FILLING INTO HARD
GELATIN CAPSULES
|
17.30 - 17.45
|
Dobson C.L. (Nottingham, UK)
CAN INTESTINAL DELIVERY OF OLEIC ACID STIMULATE THE ILEAL
BRAKE AND SLOW TABLET TRANSIT?
|
17.45 - 18.00
|
Mollee H. (Leiderdorp, The Netherlands)
THE FORMATION OF VISUALISATION OF DRIED REVERSED VESICLES
AND THEIR UPTAKE IN RATS AFTER JEJUNAL ADMINISTRATION
|
18.00
|
End of the Session
|
14.30-18.00 FRIDAY,
September 11
|
WORKSHOP 2
NEW TARGETS IN DRUG
DISCOVERY
(Part I)
14.30 - 15.00
|
Pellicciari R. (Perugia, Italy)
OXIDATIVE STRESS AND EXCITOTOXICITY: MEDICINAL CHEMISTRY
APPROACHES
|
15.00 - 15.30
|
Pratesi G. (Milan, Italy)
SELECTIVITY CRITERIA FOR THE
IDENTIFICATION OF NEW ANTITUMOR TAXANES
|
15.30 - 15.45
|
Schunack W. (Berlin, Germany)
HISTAPRODIFEN AND Nà
-SUBSTITUTED DERIVATIVES: A NEW CLASS OF SELECTIVE AND
HIGHLY POTENT HISTAMINE
H1-RECEPTOR
AGONISTS
|
15.45 - 16.00
|
Volterra A. (Milan, Italy)
CIP-A, A NEW POTENT AMPA/KAINATE RECEPTOR AGONIST,INDUCES
GLUTAMATE RELEASE IN ASTROCYTES: COMPARISON WITH AMPA
|
16.00 - 16.15
|
Sasse A. (Berlin, Germany)
CHEMICAL AND PHARMACOLOGICAL INVESTIGATION ON CHIRAL
HISTAMINE H3-RECEPTOR
ANTAGONISTS
|
16.15 - 16.45
|
Break
|
WORKSHOP 2
NEW TARGETS IN DRUG
DISCOVERY
(Part
II)
16.45 - 17.00
|
Kleuser B. (Berlin, Germany)
SPHINGOSINE-1-PHOSPHATE, A NEW ANTIPSORIATIC DRUG
|
17.00 - 17.15
|
Rastelli G. (Modena, Italy)
ADENOSINE A2A RECEPTOR: MOLECULAR MODELLING OF THE
INTERACTIONS WITH AGONISTS AND ANTAGONISTS
|
17.15 - 17.30
|
Gütschow M. (Leipzig, Germany)
INHIBITION OF HUMAN LEUKOCYTE ELASTASE BY THIENO
[2,3-d ] [1,3]OXAZIN-4-ONES
|
17.30 - 17.45
|
Ecker G. (Vienna, Austria)
STUDIES ON PROPAFENONE-TYPE MODULATORS OF MULTIDRUG
RESISTANCE: INFLUENCE OF HYDROPHOBICITY DISTRIBUTION
|
17.45 - 18.00
|
Cacciari B. (Ferrara, Italy)
SECOND GENERATION OF A2A ADENOSINE
RECEPTOR ANTAGONISTS: SYNTHESIS AND BIOLOGICAL
EVALUATION
|
18.00
|
End of the Session
|
9.00-12.30 SATURDAY,
September 12
|
WORKSHOP 3
DRUG TARGETING
(Organ Selectivity - Cell
Targeting - Cell Signalling)
(Part I)
9.00 - 9.30
|
Schechter B. (Rehovot, Israel)
IMMUNOTARGETING AND TISSUE/ORGAN DELIVERY USING THE
AVIDIN-BIOTIN SYSTEM
|
9.30 - 10.00
|
Scheideler M.A. (Baranzate di Bollate, Italy)
EVIDENCE FOR MULTIPLE STRUCTURAL DETERMINANTS REQUIRED FOR
THE ACTIVATION OF G-PROTEIN COUPLED RECEPTORS
|
10.00 - 10.15
|
Waterworth C.A. (Cardiff, UK)
TWO-LEVEL FACTORIAL ANALYSIS OF THE ROLE OF CHARGE AND
NEUTRAL LIPID COMPOSITION ON THE IN-VITRO TRANSFECTION
EFFICIENCY OF LIPOSOME-plasmid DNA (pDNA) COMPLEXES
|
10.15-10.30
|
Jääskeläinen
J. (Kuopio, Finland)
ROLE OF FUSOGENIC DOPE IN CATIONIC LIPOSOME MEDIATED
DELIVERY OF OLIGONUCLEOTIDES INTO CELLS
|
10.30 - 10.45
|
Dahlin M. (Uppsala, Sweden)
BRAIN TARGETING VIA NASAL ADMINISTRATION
|
10.45 - 11.30
|
Break
|
WORKSHOP 3
DRUG TARGETING
(Organ Selectivity - Cell
Targeting - Cell Signalling)
(Part
II)
11.30 - 11.45
|
Gabor F. (Vienna, Austria)
DOXORUBICIN-TARGETING TO COLON CARCINOMA CELLS BY MEANS OF
WHEAT GERM AGGLUTININ
|
11.45 - 12.00
|
Frahm A.W. (Freiburg, Germany)
SUBSTITUTED XANTHONES AS ANTIMYCOBACTERIAL AGENTS:
SYNTHESIS, MICROBIOLOGY AND QSAR
|
12.00 - 12.15
|
Takakura Y. (Kyoto, Japan)
EFFICIENT GENE EXPRESSION AND ANTITUMOR EFFECT FOLLOWING
DIRECT INJECTION OF INTERFERON-g GENE INTO SOLID
TUMORS
|
12.15 - 12.30
|
Severin E.S. (Moscow, Russia)
EPIDERMAL GROWTH FACTOR (EGF) CONJUGATE WITH DOXORUBICINE
(DR) PRODUCES TOXIC EFFECT ON ANTIBIOTIC RESISTANT TUMOR
CELL CULTURES
|
12.30
|
End of the Session
|
9.00-12.30 SATURDAY,
September 12
|
MINI-SYMPOSIUM
2
NEW PERSPECTIVES IN
ANALYTICAL CHEMISTRY
(Part I)
9.00 - 9.30
|
Fell A.F. (Bradford, UK)
HYPHENATED SYSTEMS IN PHARMACEUTICAL RESEARCH AND
DEVELOPMENT
|
9.30 - 10.00
|
Traldi P. (Padua, Italy)
THE EVOLUTION OF MASS SPECTROMETRY AND ITS IMPACT ON
PHARMACEUTICAL ANALYSIS
|
10.00 - 10.30
|
Gasparrini F. (Rome, Italy)
THE CHIRAL DIMENSION IN DRUG RESEARCH ANALYSIS
|
10.30 - 11.00
|
De Lorenzi E. (Pavia, Italy)
THE IMPACT OF CAPILLARY ELECTROPHORESIS IN DRUG ANALYSIS AND
BIOANALYSIS
|
11.00 - 11.30
|
Break
|
MINI-SYMPOSIUM
2
NEW PERSPECTIVES IN
ANALYTICAL CHEMISTRY
(Part
II)
11.30 - 12.00
|
Jezequel S.G. (Sandwich, UK)
BIOANALYTICAL STRATEGIES IN ADME: PRESENT NEEDS AND
CHALLENGES FOR THE FUTURE
|
12.00 - 12.30
|
Garner R.C. (Sand Hutton, UK)
BIOMEDICAL ACCELERATOR MASS SPECTROMETRY FOR ATTOMOLE
SENSITIVITY IN DRUG BIOANALYSIS
|
12.30
|
End of the Session
|
9.00-11.00 SATURDAY,
September 12
|
SYMPOSIUM
DRUGS AND CANCER:
Experimental and Clinical Pharmacology of Tumours and
Apoptosis
Chairpersons:
|
G.F. Draetta (Milan, Italy)
|
|
G. Melino (Rome, Italy)
|
9.00 - 9.30
|
Hickman J. (Manchester, UK)
APOPTOSIS AND PHARMACOLOGICAL THERAPY OF CANCER
|
9.30 - 10.00
|
Evan G. (London, UK)
CANCER: A MATTER OF LIFE AND CELL DEATH
|
10.00 - 10.30
|
Delia D. (Milan, Italy)
APOPTOSIS AND RESISTANCE TO PHARMACOLOGICAL TUMOR
THERAPY
|
10.30 - 11.00
|
Scambia G. (Rome, Italy)
APOPTOSIS AND PHARMACOLOGICAL THERAPY OF GYNAECOLOGICAL
TUMOR
|
11.00
|
End of the Session
|
11.00 - 11.30
|
Break
|
11.30 - 12.30 SATURDAY,
September 12
|
SYMPOSIUM
THE 5TH FRAMEWORK
PROGRAMME:
PERSPECTIVES AND IMPACT ON EUROPEAN RESEARCH
Chairpersons:
|
U. Scapagnini (Brussels, Belgium)
|
|
P. Fasella (Rome, Italy)
|
11.30 - 11.50
|
Scapagnini U. (Brussels, Belgium)
THE EUROPEAN PARLIAMENT ACTIVITIES FOR IMPROVING INNOVATION
AND RTD ACTIVITIES IN THE EU
|
11.50- 12.10
|
Bertazzoni U. (Brussels, Belgium)
NEW APPROACH AND CONTENTS OF THE "QUALITY OF LIFE" THEMATIC
PROGRAMME OF THE FIFTH RTD FRAMEWORK PROGRAMME OF THE
EUROPEAN COMMISSION
|
12.10 - 12.30
|
Damiani A. (Brussels, Belgium)
THE NEW RULES FOR PARTICIPATION AND FOR DISSEMINATION AND
EXPLOITATION OF RESULTS IN THE FORTHCOMING FIFTH RTD
FRAMEWORK PROGRAMME
|
12.30
|
End of the Session
|
9.00-11.00 SATURDAY,
September 12
|
SYMPOSIUM
NEW TRENDS IN
BIOAVAILABILITY - BIOEQUIVALENCE STUDIES
Chairpersons:
|
L.P. Balant (Geneve, Switzerland)
|
|
C.M. Caramella (Pavia, Italy)
|
9.00 - 9.20
|
Blume H.H. (Karlsruhe, Germany)
WHEN ARE BIOAVAILABILITY-BIOEQUIVALENCE STUDIES
NECESSARY?
|
9.20 - 9.40
|
Grahnén A. (Uppsala, Sweden)
THE BIOPHARMACEUTICAL CLASSIFICATION SYSTEM - IMPACT FOR
DRUG DEVELOPMENT
|
9.40 -10.00
|
Marzo A. (Ligornetto, Switzerland)
OPEN QUESTIONS ON BIOEQUIVALENCE: SOME PROBLEMS AND SOME
SOLUTIONS
|
10.00 - 10.10
|
General Discussion
|
10.10 - 10.30
|
Gomeni R. (Cergy, France)
INDIVIDUAL BIOEQUIVALENCE
|
10.30 - 10.50
|
Canali S. (Colleretto Giacosa, Italy)
BIOAVAILABILITY/BIOEQUIVALENCE OF BIOTECH DERIVED
PRODUCTS
|
10.50 - 11.00
|
General Discussion
|
11.00
|
End of the Session
|
|
|
|
|
Display 08.30 - 18.30 Discussion 13.00 - 14.30
|
Poster Session 6 - Drug Discovery: Pharmacological and Therapeutic Advances
Poster Session 7 - Drug Development: Delivery Systems
|
14.30-18.00 SATURDAY,
September 12
|
WORKSHOP 4
DRUG METABOLISM AND
PHARMACOKINETICS
(Part I)
14.30 - 15.00
|
Ings R.M.J. (Nerviano, Italy)
THE PREDICTION OF HUMAN PHARMACOKINETICS AND
PHARMACODYNAMICS FROM ANIMAL DATA
|
15.00 - 15.30
|
Sirtori C.R. (Milan, Italy)
PHARMACOKINETICS AND PHARMACODYNAMICS: CLINICAL POINT OF
VIEW
|
15.30 - 15.45
|
Einer-Jensen N. (Odense, Denmark)
PREFERENTIAL DISTRIBUTION TO THE BRAIN OF DIAZEPAM, BUT NOT
OF COCAINE, AFTER NASAL APPLICATION IN THE RAT
|
15.45 - 16.00
|
Iavarone L. (Verona, Italy)
PHARMACOKINETIC/PHARMACODYNAMIC RELATIONSHIPS FOR
SANFETRINEM IN A MURINE THIGH INFECTION MODEL
|
16.00 - 16.15
|
Goldsmith P. (Manchester, UK)
CONSTRUCTION OF A STEREOCHEMICAL & PHYSIOLOGICALLY BASED
PHARMACOKINETIC MODEL OF THREE BETA ADRENERGIC
ANTAGONISTS
|
16.15 - 16.30
|
Della Paschoa O.E. (Leiden, The Netherlands)
PK/PD MODELLING OF THE BEHAVIOURAL EFFECTS OF S-15535 AND
ITS METABOLITE S-32784 IN RATS
|
16.30 - 17.00
|
Break
|
WORKSHOP 4
DRUG METABOLISM AND
PHARMACOKINETICS
(Part
II)
17.00 - 17.15
|
Courtney R.D. (Manchester, UK)
INFLUENCE OF PROTEIN BINDING ON HEPATIC DISTRIBUTION
KINETICS OF ANTISENSE OLIGONUCLEOTIDES
|
17.15 - 17.30
|
Bernareggi A. (Monza, Italy)
COMPARATIVE PHARMACOKINETICS OF BBR 3464, CISPLATIN (CDDP)
AND CARBOPLATIN (CBDCA) AT ACTIVE DOSES IN THE MOUSE
|
17.30 - 18.00
|
Mazzei T. (Florence, Italy)
PHARMACODYNAMIC AND PHARMACOKINETIC CONSIDERATIONS REGARDING
NEW FLUOROQUINOLONES
|
18.00
|
End of the Session
|
14.30-18.00 SATURDAY,
September 12
|
WORKSHOP 5
CHEMICAL DEVELOPMENT
AND
DRUG CHARACTERIZATION
(Part I)
14.30 - 15.00
|
Villa M. (Bresso, Italy)
SCALE-UP IN DRUG MANUFACTURE: PROCESS DEVELOPMENT AND
OPTIMIZATION
|
15.00 - 15.30
|
Bannister R. (Cambridge, UK)
CHIRALITY IN DRUG DEVELOPMENT AND BULK DRUG SUPPLY
|
15.30 - 16.00
|
Nebuloni M. (Cologno Monzese, Italy)
POLYMORPHISM AND SCALE-UP
|
16.00 - 16.30
|
Miller J. (Strasbourg, France)
CHARACTERISATION OF DRUG REFERENCE STANDARDS: REGULATORY
APPROACH
|
16.30 - 17.00
|
Break
|
WORKSHOP 5
CHEMICAL DEVELOPMENT
AND
DRUG CHARACTERIZATION
(Part II)
17.00 - 17.15
|
Massolini G. (Pavia, Italy)
CAPILLARY ELECTROPHORESIS INVESTIGATION ON PUTATIVE BINDING
DRUGS FOR A POTENTIAL NEW THERAPEUTIC APPROACH IN DIALYSIS
RELATED AMYLOIDOSIS
|
17.15 - 17.30
|
Jee R.D. (London, UK)
DRUG IDENTIFICATION USING THE MAJOR 2ND DERIVATIVE
NEAR-INFRARED PEAKS
|
17.30 - 17.45
|
Caron G. (Turin, Italy)
pH-METRIC METHOD AS A POWERFUL TOOL TO INVESTIGATE DRUG
MOLECULAR PHYSICOCHEMICAL DESCRIPTORS
|
17.45 - 18.00
|
Viernstein H. (Vienna, Austria)
FREE ENERGY PREDICTION OF THE HOST-GUEST COMPLEXATION OF
VARIOUS CYCLODEXTRINS
|
18.00
|
End of the Session
|
14.30-16.30 SATURDAY,
September 12
|
MINI-SYMPOSIUM
3
ROUTES FOR SITE-SPECIFIC
DELIVERY
14.30 - 15.00
|
Martin G.P. (London, UK)
THE DEVELOPMENT OF POLYMERS FOR TARGETED DELIVERY OF DRUGS
TO THE COLON
|
15.00 - 15.30
|
Davis S.S. (Nottingham, UK)
PULMONARY AND NASAL ROUTES OF DELIVERY
|
15.30 - 16.00
|
Guy R.H. (Archamps, France and Genève,
Switzwerland)
TRANSDERMAL DRUG DELIVERY: OVERCOMING SKIN'S BARRIER
FUNCTION
|
16.00 - 16.30
|
General Discussion
|
16.30
|
End of the Session
|
14.30-16.30 SATURDAY,
September 12
|
MINI-SYMPOSIUM
4
BIOTECHNOLOGY DRUGS AND
THE
THERAPEUTIC REVOLUTION
14.30 - 15.00
|
Calam D.H. (Potters Bar, UK)
FUTURE PERSPECTIVES FOR BIOTECHNOLOGY PRODUCTS: REGULATORY
AND THERAPEUTIC IMPLICATIONS
|
15.00 - 15.30
|
Hancock W.S. (Palo Alto, USA)
THE USE OF HPLC AND HPCE COUPLED TO MASS SPECTROMETRY TO
CHARACTERISE THE PURITY AND SAFETY OF BIOTECHNOLOGY
DRUGS
|
15.30 - 16.00
|
Vicari G. (Rome, Italy)
SAFETY ASPECTS OF BIOTECHNOLOGICALLY-DERIVED PRODUCTS
|
16.00 - 16.30
|
Galligani L. (Munich, Germany)
EUROPEAN PATENTS IN THE BIOTECHNOLOGICAL FIELD: RELEVANT
DECISIONS OF THE BOARDS OF APPEAL OF THE EUROPEAN PATENT
OFFICE
|
16.30
|
End of the Session
|
9.00-12.30 SUNDAY,
September 13
|
MINI-SYMPOSIUM
5
NEW PROCESSES IN DRUG
DISCOVERY
9.00 - 9.30
|
Broach J.R. (Princeton, USA)
HTS: A TOOL FOR KNOWLEDGE
AND LEAD DISCOVERY
|
9.30 - 10.00
|
Warrington B.H. (Harlow, UK)
RECENT PROGRESS IN COMBINATORIAL TECHNOLOGIES
|
10.00 - 10.30
|
Gaviraghi G. (Verona, Italy)
THE IMPACT OF NEW TECHNOLOGIES IN THE LEAD OPTIMIZATION
PROCESS
|
10.30 - 11.00
|
General Discussion
|
11.00 - 11.30
|
Break
|
PLENARY LECTURE
3
11.45- 12.30
|
Rappuoli R. (Siena, Italy)
RECOMBINANT DNA TECHNOLOGY AND VACCINE DEVELOPMENT
|
12.30
|
End of the Session
|
|
|
|
|
Display 08.30 - 18.30 Discussion 13.00 - 14.30
|
Poster Session 8 - Drug Discovery: Natural Products
Poster Session 9 - Drug Discovery: Oxidative Damage
Poster Session 10 - Drug Development: Pharmacokinetics and Metabolism
Poster Session 11 - Drug Development: Cell Lines and Tissue Culture
Poster Session 12 - Drug Targeting
|
9.00-11.00 SUNDAY,
September 13
|
WORKSHOP 7
DRUG DELIVERY
9.00 - 9.30
|
Veillard M. (Vitry-sur-Seine, France)
SOME PHARMACEUTICAL STRATEGIES FOR THE FORMULATION OF
SPARINGLY SOLUBLE DRUGS
|
9.30 - 9.45
|
Junginger H.E. (Leiden, The Netherlands)
NOVEL CHITOSAN DERIVATIVES AS POLYMERIC CARRIERS FOR PEPTIDE
AND PROTEIN DRUG DELIVERY
|
9.45 - 10.00
|
Tukker J.J. (Utrecht, The Netherlands)
RELEVANCE OF THE PEPTIDE-BOND CARBONYL FOR AFFINITY FOR THE
SMALL-PEPTIDE CARRIER
|
10.00 - 10.15
|
Murdan S. (London, UK)
INVERSE TOROIDAL VESICLES: THE PRECURSORS OF TUBULAR
STRUCTURES IN SORBITAN MONOSTEARATE ORGANOGELS
|
10.15 - 10.30
|
Cassidy O. (Sunderland, UK)
ELECTROSTATIC CHARGE AND DISSOLUTION OF SURFACE MODIFIED
PHENYLBUTAZONE
|
10.30 - 10.45
|
Sarciaux J.-M. (West Lafayette, USA)
PHYSICAL STABILITY OF IgG DURING LYOPHILIZATION
|
10.45 - 11.00
|
Komarek P. (Prague, Czech Republic)
PHOTOACTIVATED PROTEINS LABELLED WITH TECHNETIUM-99mTc USING
REDOX POLYMERS: A NEW APPROACH TO RADIOPHARMACEUTICAL
PREPARATION
|
11.00
|
End of the Session
|
9.00-11.20 SUNDAY,
September 13
|
WORKSHOP 9
CHALLENGES AND
PERSPECTIVES IN
NATURAL PRODUCTS
9.00 - 9.30
|
Kolb H.C. (Basel, Switzerland)
DESIGN AND SYNTHESIS OF POTENT E-SELECTIN ANTAGONISTS
|
9.30 - 9.45
|
Gagliardi S. (Baranzate di Bollate, Italy)
SYNTHESIS OF FLUORESCENT DERIVATIVES OF BAFILOMYCIN
A1
AS PROBES FOR THE VACUOLAR
ATPase
|
9.45 - 10.00
|
Visioli F. (Milan, Italy)
FREE RADICAL-SCAVENGING ACTIVITY OF OLIVE OIL
PHENOLICS
|
10.00 - 10.15
|
Roberti M. (Bologna, Italy)
METHOXYLATED ANALOGUES OF COCAINE: IDENTIFICATION OF A WEAK
"ANTAGONIST"
|
10.15 - 10.45
|
Maffei Facino R. (Milan, Italy)
ANTIOXIDANT PROPERTIES OF GRAPE PROCYANIDINS
|
10.45 - 11.00
|
Syrovets T. (Ulm, Germany)
IDENTIFICATION OF POTENT PHARMACODYNAMIC PROPERTIES OF
BOSWELLIC ACIDS
|
11.00 - 11.20
|
Benatti P. (Pomezia, Italy)
CARNITINE SYSTEM AND PERIPHERAL ARTERIAL DISEASE
|
11.20
|
End of the Session
|
9.00-11.00 SUNDAY,
September 13
|
ROUND TABLE
THE IMPACT OF MEGAMERGERS
ON
DRUG RESEARCH AND DEVELOPMENT
Chairpersons:
|
L.M. Fuccella (Milan, Italy)
|
|
R. Paoletti (Milan, Italy)
|
9.00 - 9.15
|
Ando G. (Bridgewater, USA
WHAT FUTURE FOR DRUG
RESEARCH?
|
9.15 - 9.30
|
Cattani L. (Rome, Italy)
THE ECONOMIC IMPACT
|
9.30 - 9.45
|
Pepeu G. (Florence, Italy)
IS THERE STILL A ROLE FOR ACADEMIA?
|
9.45 - 10.00
|
Benzi G. (London, UK)
THE ROLE OF EUROPEAN INSTITUTIONS
|
10.00 - 10.15
|
Dompe' S. (Milan, Italy)
IS THERE STILL A ROLE FOR NATIONAL INDUSTRIES?
|
10.15 - 10.30
|
Criscuolo D. (Milan, Italy)
THE ROLE OF ITALY IN DEVELOPMENT
|
10.30 - 11.00
|
General Discussion
|
11.00
|
End of the Session
|
14.30-16.30 SUNDAY,
September 13
|
ROUND TABLE
NATURAL FOOD MODIFIED BY
BIOTECHNOLOGY:
NUTRITIONAL AND PHARMACEUTICAL ISSUES
Chairpersons:
|
U. Bracco (Vevey, Switzerland)
|
|
A. Poli (Milan, Italy)
|
14.30 - 15.00
|
Turk S.C.H.J. (Utrecht, The Netherlands)
FRUCTAN ACCUMULATION IN TRANSGENIC PLANTS
|
15.00 - 15.30
|
Petiard V. (Notre Dame D'Oe, France)
PLANT BIOTECHNOLOGIES FOR THE PRODUCTION OF ACTIVE COMPOUNDS BY CELL CULTURES AND WHOLE PLANTS
|
15.30 - 16.00
|
Schrott M. (Zurich, Switzerland)
BIOTECHNOLOGY: A TOOL TO INTRODUCE BIOACTIVE COMPOUNDS IN
CEREALS
|
16.00 - 16.30
|
Schuch W. (Bracknell, UK)
ENHANCING NUTRIENT CONTENTS OF FOOD AND FEED CROPS USING BIOTECHNOLOGY
|
16.30
|
End of the Session
|
14.30-16.30 SUNDAY,
September 13
|
WORKSHOP 8
CELL LINES AND TISSUE
CULTURE IN
DRUG DISCOVERY AND DEVELOPMENT
14.30 - 15.00
|
Artursson P. (Uppsala, Sweden)
REFINED METHODS FOR PREDICTION OF INTESTINAL DRUG
ABSORPTION
|
15.00 - 15.15
|
Lane M.E. (Dublin, Ireland)
CORRELATION BETWEEN PERMEABILITY CO-EFFICIENTS IN A PERFUSED
RAT MODEL AND THE CACO-2 CELL MODEL
|
15.15 - 15.30
|
Verspohl E.J. (Münster, Germany)
DUAL EFFECTS OF DIADENOSINE POLYPHOSPHATES ON INS-1
CELLS
|
15.30 - 15.45
|
Forbes B. (London, UK)
TRANSPORT CHARACTERISTICS OF FORMOTEROL AND SALBUTAMOL
ACROSS A BRONCHIAL EPITHELIAL DRUG ABSORPTION MODEL
|
15.45 - 16.00
|
Shen W.C. (Los Angeles, USA)
INSULIN ABSORPTION VIA TRANSFERRIN RECEPTOR-MEDIATED
TRANSCYTOSIS IN INTESTINAL EPITHELIUM
|
16.00 - 16.15
|
Bertolotti L. (Verona, Italy)
EVALUATION OF AN IN VITRO MODEL OF BLOOD-BRAIN BARRIER TO
ASSESS THE DRUG TRANSPORT INTO THE BRAIN
|
16.15 - 16.30
|
Jacques Y. (Archamps, France)
HEAT SEPARATED BUCCAL EPITHELIUM: A MODEL FOR STUDYING THE
PERMEABILITY OF ORAL MUCOSA
|
16.30
|
End of the Session
|
14.30-16.45 SUNDAY,
September 13
|
WORKSHOP 6
PHARMACEUTICAL
TECHNOLOGY:
MATERIAL SCIENCE
14.30 - 15.00
|
York P. (Bradford, UK)
STRATEGIES FOR PARTICLE DESIGN USING SUPERCRITICAL FLUID
TECHNOLOGIES
|
15.00 - 15.15
|
Martini A. (Milan, Italy)
ESTRAMUSTINE PHOSPHATE/BETA-CYCLODEXTRIN FORMULATION:
RATIONALE, FORMULATION DEVELOPMENT AND
BIOAVAILABILITY
|
15.15 - 15.30
|
Michalski L.A. (Nottingham, UK)
IN VITRO EVALUATION OF COLONIC DRUG DELIVERY SYSTEM BASED ON
A DISULPHIDE-LINKED POLYMER
|
15.30 - 15.45
|
Bani M. (Bresso, Italy)
PHARMACOKINETICS OF 5'ASA ADMINISTERED TO HEALTHY VOLUNTEERS
USING THE TIME CLOCK DELIVERY SYSTEM
|
15.45 - 16.00
|
Carli F. (Trieste, Italy)
ANTIINFLAMMATORY DRUG - BETACYCLODEXTRIN COMPOSITE BY
MECHANOCHEMISTRY
|
|
|
16.00 - 16.30
|
YOUNG INVESTIGATOR
AWARD
|
16.30 - 16.45
|
CLOSING
REMARKS
|
 |
In recognition of the importance of original work presented in the
Poster Sessions, a number of new EUFEPS Young Investigator
Awards will be presented for outstanding research achievements by
young scientists, 32 years old or less, who submit an Abstract for
this competition. Selection will be based on originality, importance
of work accomplished, quality of experimental design and methodology,
strength and reliability of data. The winners will be selected and
notified during the Congress. Each will receive a certificate and a
grant (corresponding to the Registration Fee) during the Young
Investigator Award Ceremony.
Further information on any aspect of the organization of EUFEPS
'98 can be obtained from the Secretariat in Milan:
EUFEPS '98
FONDAZIONE GIOVANNI LORENZINI MEDICAL SCIENCE FOUNDATION
Via Appiani, 7
20121 MILAN, Italy
Phone: (+39-2) 29.00.62.67*
Fax: (+39-2) 29.00.70.18*
E-Mail: lorenzfo@icil64.cilea.it
* Important Notice
Please note that from mid-June the Italian Telephone System
(National and International) will be modified. If you have any
difficulties in reaching us, please contact the international
operator in your country.
For inquiries in USA and CANADA, please contact:
EUFEPS '98
GIOVANNI LORENZINI MEDICAL FOUNDATION
HOUSTON, USA
Phone: (+1-713) 797.0401
Fax: (+1-713) 796.8853
E-Mail:
ajackson@bcm.tmc.edu
|